Filing Flows

Filing Flows › Orthopediatrics (KIDS) › Guidance history

Orthopediatrics (KIDS) guidance history: what it guided and what it reported

Orthopediatrics gave guidance in 3 earnings releases on file since Apr 30, 2026. Its releases raised guidance 3 times and lowered it 0 times.

Revenue

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$263M–$267M (Apr 30, 2026) → raised $265M–$269M (Aug 4, 2026) → raised $270M–$273M (Oct 27, 2026)—to be reported—

Adjusted EBITDA

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$25.0M (Aug 4, 2026) → reaffirmed $25.0M (Oct 27, 2026)—to be reported—

The latest quarter

Orthopediatrics, Q3 2026: revenue $72.7M (+19% year over year), operating margin -5.8%, net loss $5.9M, operating cash flow $4.5M. The chart follows the revenue to costs, profit and cash.

Questions

Does Orthopediatrics beat its guidance?

Orthopediatrics gave guidance in 3 earnings releases on file since Apr 30, 2026. Its releases raised guidance 3 times and lowered it 0 times.

How often does Orthopediatrics raise guidance?

Its earnings releases raised guidance 3 times and lowered it 0 times since Apr 30, 2026.

Latest guidance and outlook →

Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.